Equities

Agronomics Ltd

ANIC:LSE

Agronomics Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)8.50
  • Today's Change0.30 / 3.66%
  • Shares traded1.87m
  • 1 Year change-28.27%
  • Beta2.1460
Data delayed at least 20 minutes, as of May 13 2024 16:17 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
ASSETS
Cash And Short Term Investments183162
Total Receivables, Net0.340.100.45
Total Inventory------
Prepaid expenses------
Other current assets, total------
Total current assets------
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments14311539
Note receivable - long term9.11----
Other long term assets------
Total assets170146102
LIABILITIES
Accounts payable0.200.151.62
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1.692.28--
Total current liabilities------
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total0.060.06--
Total liabilities1.952.491.62
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital13413091
Retained earnings (accumulated deficit)34148.75
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity168144100
Total liabilities & shareholders' equity170146102
Total common shares outstanding993969800
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.